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ABSTRACT
Chromosome translocation and gene fusion are
frequent events in the human genome and are often
the cause of many types of tumor. ChimerDB is the
database of fusion sequences encompassing bioin-
formaticsanalysisofmRNAandexpressedsequence
tag (EST) sequences in the GenBank, manual collec-
tionofliteraturedataandintegrationwithotherknown
database such as OMIM. Our bioinformatics analysis
identifies the fusion transcripts that have non-
overlapping alignments at multiple genomic loci.
Fusion events at exon–exon borders are selected to
filteroutthecloningartifactsincDNAlibraryprepara-
tion.Theresultisclassifiedintotwogroups—genuine
chromosome translocation and fusion between
neighboring genes owing to intergenic splicing. We
also integrated manually collected literature and
OMIM data for chromosome translocation as an aid
to assess the validity of each fusion event. The data-
base is available at http://genome.ewha.ac.kr/
ChimerDB/ for human, mouse and rat genomes.
INTRODUCTION
Chromosomal aberrations are frequently observed in many
hematologic and solid tumors (1,2). Various large-scale and
high-throughput techniques, such as chromosome banding
(1,3), comparative genomic hybridization (CGH) (4) and
ﬂuorescence in situ hybridization (FISH) (5), are being used
in modern cancer cytogenetics to detect structural and copy
number changes in chromosomes. The most common type of
mutation among the known cancer genes is chromosomal
translocation (6). It can deregulate the gene expression by
disrupting the promoter region of the gene or by joining the
gene with enhancer elements like immunoglobulin or T-cell
receptor genes (7). Alternatively, fusion of two coding regions
creates a chimeric gene that encodes a fusion protein that
interferes with the normal regulating pathways (2,8).
The most famous example is the fusion protein BCR–ABL,
the target protein of the drug gleevec treating chronic myeloid
leukemia (CML) (8,9). CML is associated in most cases with a
chromosomal translocation between chromosomes 9 and 22
that creates the Philadelphia chromosome. The BCR gene in
chr22 is fused with the gene ABL in chr9, so called the
t(9;22)(q34;q11) translocation. The tyrosine kinase activity
of ABL is constantly activated by the BCR gene (GTPase
activator) in the fusion protein, resulting in the rapid cellular
mitosis and inability of the cell to perform apoptosis. Gleevec
inhibits the tyrosine kinase ability of the BCR–ABL fusion
protein. Successful development of gleevec opened an era of
targeted molecular therapy.
Chimeric sequences can be generated from other mechan-
isms too. Two adjacent, independent genes may be co-trans-
cribed and the intergenic region is spliced out so that the
resulting fused transcript possesses exons from both genes
(10). This phenomenon, termed as cotranscription and inter-
genic splicing (CoTIS), can lead to fusion protein or altered
promoter region for the downstream gene in the same way as
chromosome translocation. Furthermore, trans-splicing can
join two independently transcribed mRNA sequences at
canonical exon–exon borders. Even though several cases of
natural trans-splicing are reported in human (11,12), it is gen-
erally considered to be rare and will be ignored in this work.
Given the importance of chromosome aberration in cancer
detection, prognosis and target identiﬁcation, it is quite natural
to search for chimeric sequences in the GenBank. Alterbi and
co-workers (13) developed a screening procedure to identify
heterologous, spliced mRNAs with potential origin from chro-
mosomal translocation, mRNA trans-splicing and multi-locus
transcription. Hahn et al. (14) extended this approach to
include expressed sequence tag (EST) sequences that expan-
ded the search scope signiﬁcantly. They experimentally veri-
ﬁedthe predicted IRA1–RGS17 fusioninthebreast cancer cell
line MCF7. However, they deliberately discarded fusion cases
between neighboring genes.
Curated databases are also available from cancer cytogen-
etics community. NCBI’s database of cancer chromosomes
(15) integrated the NCI/NCBI SKY/M-FISH and CGH data-
base and the NCI Mitelman Database of Chromosome Aber-
rations in Cancers. The Cancer Genome Project at the Sanger
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doi:10.1093/nar/gkj019Institute maintains a list of cancer genes based on published
scientiﬁc literatures(6).Mutationdataandassociatedinforma-
tion for these cancer genes are stored in the COSMIC database
(16).The‘AtlasofGeneticsandCytogeneticsinOncologyand
Haematology’ is a peer-reviewed resource that contains con-
cise and updated cards on genes involved in cancer, cytogen-
etics and clinical entities in oncology, and cancer-prone
diseases (17).
In this paper, we describe a new database of fusion genes,
ChimerDB. It aims to be a knowledgebase that integrates
bioinformatics analysis of transcript sequences (mRNA and
EST), literature data from scientiﬁc journals (6) and OMIM
data on translocation (18). It should be a valuable resource for
developing cancer biomarkers and drug targets.
DATABASE CONSTRUCTION
In silico identification of fusion transcripts
All mRNA and EST sequences in the GenBank (Release 148;
June 15, 2005) were aligned onto the human genome (NCBI
Build 35) using the BLAT program (19). Minimum length and
percent identity of valid alignments were 100 bp and 93%,
respectively. Transcripts with two non-overlapping, contigu-
ousalignments were selected asfusion candidates. Small over-
lap (<10 bp) was allowed due to uncertainty in BLAT
alignments. Alignments in the same chromosome were restric-
ted to be in opposite orientation to avoid fusion by CoTIS. We
found 261 mRNA and 2484 EST sequences as fusion candid-
ates, including artiﬁcial chimeras created by accidental liga-
tion of different cDNAs during the cloning procedure.
Genuine and artiﬁcial chimeras can be distinguished by exam-
ining the fusion boundaries. Fusion points in true chimeras
usually coincide with a splice site since chromosome breakage
tends to take place in long intronic regions rather than in short
exons (14). Allowing 10 bp deviation from known splice sites,
we obtained 159 mRNA and 258 EST sequences as reliable
fusion transcripts. They constitute 355 fusion cases involving
638 genes.
Fusion cases owing to CoTIS can be identiﬁed using the
ECgene clustering system (20,21). ECgene clusters sequences
that share any splice sites in the genomic alignment, taking
gene orientation into consideration. Fusion transcripts cause
two neighboring genes to join to form a single cluster in the
ECgene system. Therefore, we searched for ECgene clusters
(Version 1.2) that contained two non-overlapping known
genes and identiﬁed fusion transcripts. We found 223
mRNA and 396 EST sequences encoding 337 cases of
CoTIS. Fusion by CoTIS creates a subtle problem in the
genome-based EST clustering procedure that groups
sequences sharing any splice sites. They should be identiﬁed
and removed in advance.
Literature database
Journal publication is the single most important source of
scientiﬁc knowledge. PubMed search for publications report-
ing fusion events owing to chromosome translocation gave
2945 manuscripts. Manual inspection of abstract produced
254 fusion cases involving 286 genes. We also imported the
list of cancer genes associated with chromosome translocation
from the Cancer Genome Project at the Sanger Institute (6).
Current cancer gene census contains 257 translocation cases
involving 346 genes, most of which coincide with our PubMed
search result.
OMIM database is another knowledgebase of human genes
and genetic disorders (18). We searched OMIM database for
records with chromosome translocations. Manual inspection
of 850 records gave 320 translocation cases with 597 genes.
Literature databases should greatly extend the utility of fusion
database by providing literature proof and relevant medical
information for each computationally identiﬁed event.
Database integration
One of the major problems in dealing with heterogeneous
databases, especially the literature data, is the use of aliases
for the same gene. This is the source of redundant and frag-
mented entries. All records use the ofﬁcial HUGO gene to
avoid this problem. Alias ﬁeld in Entrez Gene database
(22) was used to deal with different names for the same
gene. In silico results from transcript mapping, literature
and OMIM data were all integrated according to this ofﬁcial
gene symbols. Furthermore, Mitelman’s recurrent aberration
database and the Atlas Chromosomes in Cancer data were also
integrated into ChimerDB.
Table 1 is the summary statistics of ChimerDB. Currently,
ChimerDB contains 1258 fusion cases that involve 1777
genes, 381 mRNA and 654 EST sequences. Assuming total
number of human genes 25000, this implies that 4.4% of
human genes are involved in chromosome translocation and
another 2.7% of human genes show fusion between neigh-
boring genes (CoTIS). It should be noted that overlap between
the transcript mapping data and other known databases is not
large. This suggests that majority of known chromosome
translocations are not supported by transcript data, such as
mRNA and EST. Unless transcripts were discarded owing
to low alignment quality, they would be from non-
sequence-based methods and it would be interesting to obtain
clone-based sequence data for those cases.
WEB INTERFACE
The contents of ChimerDB can be accessed at http://genome.
ewha.ac.kr/ChimerDB. It supports various types of queries
Table 1. Summary statistics of ChimerDB
Data source Fusion cases Genes
a mRNA EST
Transcript mapping
b
Translocation 355 638 159 258
CoTIS 337 674 223 396
PubMed literature 254 286 (76)
Sanger CGP 257 346 (80)
OMIM records 320 597 (66)
Mitelman breakpoint 144 158 (54)
Atlas chromosomes 307 (61)
Total (non-redundant) 1258 1777 381 654
Known genes 1009 1528
EST clusters
c 249 249
cEST clusters come from 151 translocation and 98 CoTIS cases.
aNumbers in the parentheses indicate common genes with translocation data.
bTranscript mapping data include EST clusters as well as known genes.
D22 Nucleic Acids Research, 2006, Vol. 34, Database issuesuch as gene name and cytogenetic band position. Query can
be a breakpoint (e.g. AML1) or a fusion event (e.g. BCR–
ABL1).We alsosupport searches by site and/or diagnosis as in
the NCBI Cancer Chromosomes.
Search result page shows all relevant fusion cases with
available types of data. Details page opens an output page
for a speciﬁc fusion case that consists of a summary table,
detailed information table and fusion transcript table as shown
in Figure 1A. It includes extensive links to relevant resources,
such as the Entrez Gene, OMIM and PubMed databases. Links
to NCBI Cancer Chromosomes provide detailed information
on SKY/M-FISH and CGH and Mitelman databases—primary
databases for cancer cytogenetics. Links to Atlas of Genetics
and Cytogenetics in Oncology and Haematology database
allow access to community efforts to annotate cancer genes,
rich in cytogenetic and clinical information. The transcript
table in Figure 1A shows the tissue and pathology information
for EST sequences. It also describes properties of the fusion—
transcript direction, aligned region, number of exons, devi-
ation of fusion boundary from known splice site and so on.
Intact and affected domains before and after translocation are
also summarized using the InterPro database (23).
A
B
Figure1.(A)PartoftheoutputpagefromChimerDB.(B)CustomgenomebrowserforRUNX1T1genomiclocustovisualizefusiontranscripts.Reddotindicatesthe
fusion point.
Nucleic Acids Research, 2006, Vol. 34, Database issue D23Figure 1B is the custom genome browser showing align-
mentoffusiontranscriptsineach gene. Breakpointsand fusion
partner genes can be immediately recognized in the viewer. It
also shows the position of functional domains present in the
gene.
Most fusion genes owing to CoTIS do not have detailed
information on their functional signiﬁcance yet. Therefore, we
simply provide the minimal information—fused genes,
genomic locus, functional domains, alignment browser and
exon/intron properties.
FUTURE DIRECTIONS
ChimerDB is an integrated database for fusion sequences that
includes bioinformatics analysis, literature data and OMIM
data. However, functional signiﬁcance of fusion events should
beexaminedthoroughlysothatthesefusioneventscouldserve
as drug targets for cancer treatment. Expression analysis of
fusedtranscriptsindifferent histological and pathological con-
ditions should be performed with the bioinformatics analysis
such as domain and promoter changes, frame shift and so on.
Integrative approach that combines high-throughput tech-
niques,suchasSKY,CGH,SNPchip,microarray,proteomics,
interactions and pathway analysis, would prove to be powerful
in elucidating the functional signiﬁcance of fusion genes.
ChimerDB will continue to integrate relevant data available
in public.
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